Abstract
Efficacy of Prednisone in the Treatment of Ocular Myasthenia (EPITOME) is a multicenter, randomized, double blind, placebo-controlled trial that is being conducted under the auspices of the Muscle Study Group. EPITOME is the first randomized control trial in patients with ocular myasthenia and aims to evaluate the efficacy and tolerability of prednisone over a period of four months in patients with newly diagnosed ocular myasthenia whose symptoms have failed to remit in response to a trial of cholinesterase inhibitor therapy.
| Original language | English |
|---|---|
| Pages (from-to) | 17-22 |
| Number of pages | 6 |
| Journal | Annals of the New York Academy of Sciences |
| Volume | 1275 |
| Issue number | 1 |
| DOIs | |
| State | Published - Dec 1 2012 |
Fingerprint
Keywords
- Clinical trial
- Evidence-based medicine
- Ocular myasthenia
- Steroids
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)
- History and Philosophy of Science
Cite this
Design of the Efficacy of Prednisone in the Treatment of Ocular Myasthenia (EPITOME) trial. / Benatar, Michael G; Sanders, Donald B.; Wolfe, Gil I.; McDermott, Michael P.; Tawil, Rabi.
In: Annals of the New York Academy of Sciences, Vol. 1275, No. 1, 01.12.2012, p. 17-22.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Design of the Efficacy of Prednisone in the Treatment of Ocular Myasthenia (EPITOME) trial
AU - Benatar, Michael G
AU - Sanders, Donald B.
AU - Wolfe, Gil I.
AU - McDermott, Michael P.
AU - Tawil, Rabi
PY - 2012/12/1
Y1 - 2012/12/1
N2 - Efficacy of Prednisone in the Treatment of Ocular Myasthenia (EPITOME) is a multicenter, randomized, double blind, placebo-controlled trial that is being conducted under the auspices of the Muscle Study Group. EPITOME is the first randomized control trial in patients with ocular myasthenia and aims to evaluate the efficacy and tolerability of prednisone over a period of four months in patients with newly diagnosed ocular myasthenia whose symptoms have failed to remit in response to a trial of cholinesterase inhibitor therapy.
AB - Efficacy of Prednisone in the Treatment of Ocular Myasthenia (EPITOME) is a multicenter, randomized, double blind, placebo-controlled trial that is being conducted under the auspices of the Muscle Study Group. EPITOME is the first randomized control trial in patients with ocular myasthenia and aims to evaluate the efficacy and tolerability of prednisone over a period of four months in patients with newly diagnosed ocular myasthenia whose symptoms have failed to remit in response to a trial of cholinesterase inhibitor therapy.
KW - Clinical trial
KW - Evidence-based medicine
KW - Ocular myasthenia
KW - Steroids
UR - http://www.scopus.com/inward/record.url?scp=84871591629&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84871591629&partnerID=8YFLogxK
U2 - 10.1111/j.1749-6632.2012.06780.x
DO - 10.1111/j.1749-6632.2012.06780.x
M3 - Article
C2 - 23278573
AN - SCOPUS:84871591629
VL - 1275
SP - 17
EP - 22
JO - Annals of the New York Academy of Sciences
JF - Annals of the New York Academy of Sciences
SN - 0077-8923
IS - 1
ER -